Por favor, use este identificador para citar o enlazar este ítem:http://uvadoc.uva.es/handle/10324/33510
Título
A novel lipase-catalyzed method for preparing ELR-based bioconjugates
Autor
Año del Documento
2019
Editorial
Elsevier
Descripción
Producción Científica
Documento Fuente
International Journal of Biological Macromolecules, 2019, Volume 121, Pages 752-759
Resumen
Herein we present a novel one-pot method for the chemical modification of elastin-like recombinamers (ELRs) in a mild and efficient manner involving enzymatic catalysis with Candida antarctica lipase B. The introduction of different functionalities into such ELRs could open up new possibilities for the development of advanced biomaterials for regenerative medicine and, specifically, for controlled drug delivery given their additional ability to respond to stimuli other than pH or temperature, such as glucose concentration or electromagnetic radiation.
Candida antarctica lipase B immobilized on a macroporous acrylic resin (Novozym 435) was used to enzymatically couple different aminated substrates to a recombinamer containing carboxylic groups along its amino acid chain by way of an amidation reaction. A preliminary study of the kinetics of this amidation in response to different reaction conditions, such as solvent, temperature or reagent ratio, was carried out using a phenylazobenzene derivative (azo-NH2) as a model. The optimal amidation conditions were used to couple other amine reagents, such as phenylboronic acid (FB-NH2) or polyethylene glycol (PEG-NH2), thus allowing us to obtain photoresponsive, glucose-responsive or PEGylated ELRs that could potentially be useful as sensors in devices for controlled drug delivery.
Palabras Clave
Elastina
Modificación enzimática
Elastine
Enzymatic modification
ISSN
0141-8130
Revisión por pares
SI
Patrocinador
European Social Fund (ESF) and European Regional Development Fund (ERDF)
Comisión Europea (proyectos NMP-2014-646075, HEALTH-F4-2011-278557, PITN-GA-2012-317306 y MSCA-ITN-2014-642687),
Ministerio de Economía, Industria y Competitividad (Projects MAT2015-68901-R, MAT2016-79435-R and MAT2016-78903-R)
Junta de Castilla y León (programa de apoyo a proyectos de investigación – Ref. VA244U13 y VA313U14)
CIBER-BBN, Instituto de Salud Carlos III a través de la Red de Medicina Regenerativa y Terapia Celular de Castilla y León, Novozymes®
Comisión Europea (proyectos NMP-2014-646075, HEALTH-F4-2011-278557, PITN-GA-2012-317306 y MSCA-ITN-2014-642687),
Ministerio de Economía, Industria y Competitividad (Projects MAT2015-68901-R, MAT2016-79435-R and MAT2016-78903-R)
Junta de Castilla y León (programa de apoyo a proyectos de investigación – Ref. VA244U13 y VA313U14)
CIBER-BBN, Instituto de Salud Carlos III a través de la Red de Medicina Regenerativa y Terapia Celular de Castilla y León, Novozymes®
Version del Editor
Propietario de los Derechos
© 2018 Elsevier
Idioma
eng
Derechos
openAccess
Aparece en las colecciones
Ficheros en el ítem